Leptin Induces a Proliferative Response in Breast Cancer Cells but Not in Normal Breast Cells

REFERENCES

• Bergstrom A, Pisani P, Tenet V, Wolk A, and Adami HO: Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91,421–430, 2001.
   PubMed Web of Science ®Google Scholar
• Bianchini F, Kaaks R, and Vainio H: Overweight, obesity, and cancer risk. Lancet Oncol 3,565–574, 2002.
   PubMed Web of Science ®Google Scholar
• Maccio A, Madeddu, and Mantovani G: Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives. Obes Rev 10,660–670, 2009.
   PubMed Web of Science ®Google Scholar
• Daling, JR, Malone KE, Doody DR, Johnson LG, Gralow JR, et al.: Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92,720–729, 2001.
   PubMed Web of Science ®Google Scholar
• Irigaray P, Newby JA, Lacomme S, and Belpomme D: Overweight/obesity and cancer genesis: more than a biological link. Biomed Pharmacother 61,665–678, 2007.
   PubMed Web of Science ®Google Scholar
• Key TJ, Allen NE, Verkasalo PK, and Banks E: Energy balance and cancer: the role of sex hormones. Proc Nutr Soc, 60,81–89, 2001.
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, and Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316,129–139, 2010.
   PubMed Web of Science ®Google Scholar
• Somasundar P, McFadden DW, Hileman SM, and Vona-Davis L: Leptin is a growth factor in cancer. J Surg Res 116,337–349, 2004.
   PubMed Web of Science ®Google Scholar
• Liuzzi A, Savia G, Tagliaferri M, Lucantoni R, Berselli ME, et al.: Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord 23,1066–1073, 1999.
   PubMed Web of Science ®Google Scholar
• Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, et al.: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392,398–401, 1998.
   PubMed Web of Science ®Google Scholar
• Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM, et al.: Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat 119,367–370, 2010.
   PubMed Web of Science ®Google Scholar
• Tessitore., Vizio B, Pesola D, Cecchini F, Mussa A, et al.: Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 24,1529–1535, 2004.
   PubMed Web of Science ®Google Scholar
• Hou, WK, Xu YX, Yu T, Zhang L, Zhang WW, et al.: Adipocytokines and breast cancer risk. Chin Med J (Engl) 120,1592–1596, 2007.
   PubMed Web of Science ®Google Scholar
• Ozet A, Arpaci F, Yilmaz MI, Ayta H, Ozturk B, et al.: Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 31,424–427, 2001.
   PubMed Web of Science ®Google Scholar
• Han CZ, Du LL, Jing JX, Zhao XW, Tian FG, et al.: Associations among lipids, leptin, and leptin receptor gene Gin223Arg polymorphisms and breast cancer in China. Biol Trace Elem Res 126,38–48, 2008.
   PubMed Web of Science ®Google Scholar
• Carroll PA, Healy L, Lysaght J, Boyle T, Reynolds JV, et al.: Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer. Mol Carcinog 50,643–651, 2011.
   PubMed Web of Science ®Google Scholar
• Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, et al.: Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237,109–114, 2006.
   PubMed Web of Science ®Google Scholar
• Jarde T, Caldefie-Chézet F, Damez M, Mishellany F, Penault-Llorca F, et al.: Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma. Oncol Rep 19,905–911, 2008.
   PubMed Web of Science ®Google Scholar
• Jeong YJ, Bong JG, Park SH, Choi JH, and Oh HK: Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer 14,96–103, 2012.
   Web of Science ®Google Scholar
• Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, et al., High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118,1414–1419, 2006.
   PubMed Web of Science ®Google Scholar
• Cleary MP, Phillips FC, Getzin SC, Jacobson TL, Jacobson MK, et al.: Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 77,205–215, 2003.
   PubMed Web of Science ®Google Scholar
• Cleary MP, Juneja SC, Phillips FC, Hu X, Grande JP, et al.: Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med (Maywood) 229,182–193, 2004.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich J, et al.: Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer 18,491–503, 2011.
   PubMed Web of Science ®Google Scholar
• Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, et al.: Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res 67,3412–3421, 2007.
   PubMed Web of Science ®Google Scholar
• Gonzalez RR, et al.: Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281,26320–26328, 2006.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez RR, Cherfils S, Escobar M, Yoo JH, Carino C, et al.: Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation. Cell Signal 22,1350–1362, 2010.
   PubMed Web of Science ®Google Scholar
• Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R, et al.: Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293,622–628, 2002.
   PubMed Web of Science ®Google Scholar
• Soma D, Kitayama J, Yamashita H, Miyato H, Ishikawa M, et al.: Leptin augments proliferation of breast cancer cells via transactivation of HER2. J Surg Res 149,9–14, 2008.
   PubMed Web of Science ®Google Scholar
• Yin N, Wang D, Zhang H, Yi X, Sun X, et al.: Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 64,5870–5855, 2004.
   PubMed Web of Science ®Google Scholar
• Nkhata KJ, Ray A, Schuster TF, Grossmann ME, and Cleary MP: Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep 21,1611–1619, 2009.
   PubMed Web of Science ®Google Scholar
• Fusco R, Galgani M, Procaccini C, Franco R, Pirozzi G, et al.: Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. Endocr Relat Cancer 17,373–382, 2010.
   PubMed Web of Science ®Google Scholar
• Ray A, Nkhata KJ, and Cleary MP: Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30,1499–1509, 2007.
   PubMed Web of Science ®Google Scholar
• McCormack D, Schneider J, McDonald D, and McFaddenD: The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation. Am J Surg 202,541–544, 2011.
   PubMed Web of Science ®Google Scholar
• Otvos L Jr, Kovalszky I, Riolfi M, Ferla R, Olah J, et al.: Efficacity of leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer 47,1578–1584, 2011.
   PubMed Web of Science ®Google Scholar
• Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, et al.: Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 278,28668–28676, 2003.
   PubMed Web of Science ®Google Scholar
• Catalano S, Mauro L, Marsico S, Giordano C, Rizza P, et al.: Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J Biol Chem 279,19908–19915, 2004.
   PubMed Web of Science ®Google Scholar
• Debiton E, Madelmont JC, Legault J, and Barthomeuf C: Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion. Cancer Chemother Pharmacol 51,474–482, 2003.
   PubMed Web of Science ®Google Scholar
• Goncalves-Mendes N, Blanchon L, Meiniel A, Dastugue B, and Sapin V: Placental expression of SCO-spondin during mouse and human development. Gene Expr Patterns 4,309–314, 2004.
   PubMed Web of Science ®Google Scholar
• Yang C, Yu B, Zhou D, and Chen S: Regulation of aromatase promoter activity in human breast tissue by nuclear receptors. Oncogene 21,2854–2863, 2002.
   PubMed Web of Science ®Google Scholar
• Chen C, Chang YC, Liu CL, Chang KJ, and Guo IC: Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat 98,121–132, 2006.
   PubMed Web of Science ®Google Scholar
• Garofalo C, Sisci D, and Surmacz E: Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10,6466–6475, 2004.
   PubMed Web of Science ®Google Scholar
• Caldefie-Chezet F., Damez M, de Latour M, Konska G, Mishellani F, et al.: Leptin: a proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commun 334,737–741, 2005.
   PubMed Web of Science ®Google Scholar
• Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, et al.: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 12,1447–1453, 2006.
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Kitayama J, and Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10,4325–4331, 2004.
   PubMed Web of Science ®Google Scholar
• Jiang H, Yu J, Guo H, Song H, and Chen S: Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Biochem Biophys Res Commun 368,1–5, 2008.
   PubMed Web of Science ®Google Scholar
• Jarde T, Caldefie-Chézet F, Goncalves-Mendes N, Mishellany F, Buechler C, et al., Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer 16,1197–1210, 2009.
   PubMed Web of Science ®Google Scholar
• Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, et al.: Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 1592,107–116, 2002.
   PubMed Web of Science ®Google Scholar
• Saxena NK, Vertino PM, Anania FA, and Sharma D: Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem 282,13316–13325, 2007.
   PubMed Web of Science ®Google Scholar
• Hu X, Juneja SC, Maihle NJ, and Cleary MP: Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94,1704–1711, 2002.
   PubMed Web of Science ®Google Scholar
• Laud K, Gourdou I, Pessemesse L, Peyrat JP, and Djiane J: Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188,219–226, 2002.
   PubMed Web of Science ®Google Scholar
• Jarde T, Perrier S, Vasson MP and Caldefie-Chézet F: Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47,33–43, 2011.
   PubMed Web of Science ®Google Scholar
• Khandekar MJ, Cohen P, and Spiegelman, BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11,886–895, 2011.
   PubMed Web of Science ®Google Scholar